Drugs / KN015
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03192527 | Jun 2017 → Mar 2019 | female infertility | Alphamab Jilin Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KN015 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03192527 ↗ |
| Modality | Protein / enzyme biologic | “KN015 is a long-acting, recombinant human follicle-stimulating hormone Fc fusion protein” PMID 36537742 ↗ Dec 2022 |
| Route | Subcutaneous | “After subcutaneous administration of a single dose” PMID 36537742 ↗ Dec 2022 |